pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
raps·1d ago·1 min read
save

WHO releases updated draft guideline to strengthen quality risk management for manufacturers and regulators

Oct 6, 2026·read at raps ↗RegulatoryNeutral

The World Health Organization has issued an updated draft guideline designed to help manufacturers establish effective quality risk management systems and to aid regulators in planning inspections.

The new guidance incorporates concepts from the International Council for Harmonisation's Q9 (R1) guideline on quality risk management.

By aligning with ICH Q9, the WHO aims to promote consistent risk-based approaches that enhance product quality and patient safety.

The draft will be open for public comment before final adoption, allowing stakeholders to provide feedback on its implementation.

source

This writeup was produced by pharmadog from original reporting by raps.

Original headline: “WHO drafts updated guideline on quality risk management”

read at raps ↗
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 1d agoRecon: BD pledges $19B US investment; McKesson, CD&R to buy Option Care for $5.8Braps
  • 2d agoFDA seeks input on studying psychedelic ibogaineraps
  • 2d agoFDA admonishes Evolus for ‘false and misleading’ social media claimsraps
  • 2d agoRecon: Bayer plans for $2.2B manufacturing site in Ohio; FDA’s CDER launches clinical trial modernization officeraps
  • 2d agoAsia-Pacific Roundup: TGA starts 5-year transition to new Australian medicine labeling standardsraps